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Objectives:  To assess whether variation in the provision of cancer specialist nurses in 
England is associated with variation in positive experiences of care by patients 
undergoing treatment for cancer. 
Design: Cross sectional study using routinely collected national survey data.  
Setting: English acute hospital NHS trusts  
Participants: Patients with a primary diagnosis of cancer who attended hospital as an 
inpatient or outpatient day case in the first three months of 2010  in 158 NHS trusts who 
responded to a national survey (n=67,713, response rate 67%) 
Main Outcome Measures:  Patient perceptions of coordination of care, quality of 
information provision, emotional support and support for symptom management.  
Results: Patients of trusts that had the fewest patients per specialist nurse were more 
likely to report that people treating and caring for them worked well together (adjusted 
odds ratio 1.08, 95% Confidence Interval 1.01 - 1.15  p=0.02), and enough emotional 
support during ambulatory treatment (1.15, 1.01 - 1.32  p=0.04) but were no more likely 
to report being given the right amount of information (0.96, 0.88 –to 1.05  p=0.38) when 
compared to patients in trusts with the most patients per specialist nurse. Breast cancer 
patients undergoing chemotherapy in the trusts with fewer patients per specialist nurse 
were more likely to report good support for control of side effects from chemotherapy 
(1.34, 1.02 to1.75, p=0.03). 
Conclusions: Cancer patients’ experiences of care coordination and emotional support 
are better in trusts with more specialist nurses. The absolute differences are small and 
further research must investigate whether particular roles or service configurations are 
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associated with better experience. 
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Introduction 
 
Specialist nurses are identified as having a key role in delivering quality care to patients 
undergoing treatment for cancer. (1-4)    In England, cancer specialist nurses fulfill a role 
intended to enhance coordination of care and provision of information as well as to 
provide emotional support and supportive interventions (e,g. symptom control) for 
patients with cancer.(1) Support for expansion of the specialist nurse workforce is strong, 
with patient and national clinical advisory groups calling for all cancer patients to have 
access to a specialist nurse and significant emphasis was placed on the function of 
specialist nurses in delivering a national plan for improving the quality of cancer care. (2-
4) Although specialist nursing roles have been in existence for some decades in the UK, 
there remain significant variation in patients’ access to specialist nurses . (5, 6)  Many 
posts are initially funded by a national cancer charity, Macmillan Cancer Support, in the 
expectation that the NHS will continue funding. However, further expansion and 
investment is threatened by cost containment measures, with surveys suggesting 
significant job insecurity among post holders.(7)  
 
Given the diverse groups of patients and varying roles adopted by specialist nurses, 
current evidence is insufficient to be certain that a broad policy of investment in the 
workforce as a whole will deliver the intended goals of improved coordination, 
communication, emotional support and supportive interventions for symptoms.  Equally 
the consequences of a policy of disinvestment are uncertain. There are several trials 
focusing on defined therapeutic interventions delivered by specialist nurses for specific 
groups of patients, most notably for those with breast and lung cancer. (8-11)  However, 
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there are no assessments of the impact of incorporating specialist nurses into the 
workforce outside such trials.   In acute general care, analysis of associations between 
staff nurse to patient ratios and patient outcomes using administrative data have been 
used to estimate the impact of structural workforce changes, such as an increase in the 
number of registered nurses in hospitals.  These studies have shown associations between 
improved care quality and a larger and more skilled nursing workforce and have 
influenced policy and legislation setting minimum nurse staffing levels.(12, 13)  No 
equivalent evidence exists to guide policy for specialist nurse staffing. 
 
In 2010 a national survey of cancer patients’ experiences of care was undertaken in 
England by the NHS National Cancer Action Team. (14) This survey explored a broad 
range of issues and included items concerning areas where specialist nurses might 
improve care. Results from this survey showed that patients who reported that they had 
access to a clinical nurse specialist also reported that they were more likely to be 
provided with information and given choices about their treatment. (14) However, there 
is variation in the provision of specialist nurses by tumour group, and the relationship 
could be confounded. It is also unclear if the variation is in any way related to the size of 
the available workforce as opposed to more general variation in service configuration. 
Furthermore, while the associations reported from the survey are important, they are 
primarily related to a functional process (e.g. provision of written information) as 
opposed to the desired outcome (successful delivery of information titrated to need). In 
this study we use these secondary data to look for evidence of an association between the 
size of workforce relative to the number of patients and patient experiences in order to 
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explore whether the hypothesized benefits of providing more specialist nurses for people 
with cancer are realised. 
 
Methods 
We used two existing data sets for this study. The National Cancer Patient Experience 
Survey was sent to all adult (16+) patients with a diagnosis of cancer (ICD 10 codes C00-
C99, D05 excluding C44) who attended one of 158 NHS trusts (inpatient or outpatient) 
between 1st January 2010 and 31
st
 March 2010. (14) The data were obtained from the UK 
data archive. Responses were received from 67,713 people (response rate  67%). Cases 
with demographic information, but without survey responses relevant to our analysis 
were excluded reducing the sample size to 67,043.   The data set also contains patient 
demographic and diagnostic information including ICD10 code and tumour site derived 
from administrative sources. The number of patients per trust was defined by the survey 
population, which is equivalent to the number of unique adult patients (aged 16 and 
above) with a primary cancer diagnosis and who attended the trust as inpatient or day 
case in the first quarter in 2010.   
From the Patient Experience Survey, we identified items which match the overall goals of 
the specialist nurse workforce as stated in the policy and policy related documents cited 
above(1-4): that is coordination, information, emotional support and supportive 
interventions. We chose items that were overall summaries of relevant experience 
wherever possible. The final set of items was agreed by reaching a consensus among the 
research team. We did this without direct reference to the previously noted associations 
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between patient report of having access to a specialist nurse and patient experience so as 
to avoid biasing our selection to those items most likely to favour the specialist nurse. In 
addition to questions about access to a specialist nurse we used three general items, 
applicable to all patients, which asked about whether the team caring for the patient 
worked well together, whether they felt like they were treated as a ‘set of symptoms’ 
rather than a whole person (coordination), and whether or not they were given the right 
amount of information (information / communication). Additionally we used items which 
asked about emotional support and support to control side effects of chemotherapy and 
radiotherapy (supportive interventions) [see table 1 for precise wording]. These items 
were asked in relation to patients attending outpatient care only. 
In all cases we compared the most favourable response with others response categories 
and omitted responses which did not have a clear evaluative element. For example, we 
judged that the response ‘I have not tried to contact him or her’ was not an evaluation of 
the experience of contacting a specialist nurse.  
 
We obtained details of the specialist cancer nurse workforce from the 2010 Census of 
Cancer Specialist Nurses in England. (15) A survey of directors of nursing was 
undertaken in April 2010. They were asked to give whole time equivalents (WTE) and 
area of practice of all cancer specialist registered nurses (including but not restricted to 
job titles such as nurse practitioner, consultant and specialist) in NHS pay bands 6 to 9 
(that is excluding newly qualified junior registered nurses). Nurses specialising in 
palliative care and community nurses were excluded. Staffing was operationalised as 
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patients per whole WTE specialist nurse. For a planned sub-group analysis focusing on 
specialist nurses for breast cancer and patients with breast cancer, we calculated patient 
per specialist breast cancer nurse ratios. For this analysis, we assumed that the number of 
patients in the sample with breast cancer was an unbiased estimator of the number in the 
target population, as we were unable to identify the diagnoses of non-responders.  To 
assess the relationship of experience with staffing we divided the sample into three equal 
sized groups of trusts based on staffing levels (tertiles). We chose this approach because 
we did not wish to assume a simple linear relationship but had no external norms to draw 
on that we could use set thresholds for the analysis and to base assessments as to whether 
a given level of staffing was high or low. The existing literature simply illustrates the 
wide variation that exists(6). A  low staffed trust had >43.1 patients per WTE, medium 
43.1 to 30.1 patients per WTE and a high staffed trust had< 30.1 patients per WTE 
specialist nurse. Low staffed trusts were used as the reference category. 
Trusts were fitted as random effects to compute odds ratios with 95% confidence limits 
for the effect of staffing in a binary generalized linear mixed regression model. To 
control for differences in the patient population several control factors were included in 
the analysis: gender (except for a breast cancer sub group analysis – see below), age (as a 
quadratic term), deprivation value (the square root of the index of multiple deprivation 
centile), the primary ICD 10 cancer group and whether patients had attended for surgery, 
radiotherapy or chemotherapy (based on responses to the survey). Cases with missing 
values were omitted from the analysis. The sample size available for analysis varied from 
66,339 to 15,201 (table 1).  All analyses were conducted with R 2.13 (16) and lme4 (17) 
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statistical software.    
 
Results 
The characteristics of the sample are show in table 1. Detailed descriptive analysis has 
been published in the full report of each survey. (15, 18) Overall, eighty four percent of 
patients answered ‘yes’ to the question “Were you given the name of a Clinical Nurse 
Specialist who would be in charge of your care?”. Most patients reported positive 
experiences for all the questions we considered, although only 59% responded that the 
people caring for them worked well together (table 2). There was considerable variation 
across trusts for most variables. For example, overall 87% of patients felt that they were 
given the right amount of information, which was the most positive rated item, but trust 
level responses ranged from 75% to 96%.  
 
The odds of being given the name of a specialist nurse were significantly higher in trusts 
with medium (adjusted odds ratio [OR] 1.09, 95% confidence interval [C I] 1.02 to 1.16) 
and high specialist nurse staffing (OR1.11, CI 1.03 to 1.21) compared to those with low 
staffing. Patients were more likely to report that they find it easy to contact their 
specialist nurse in these trusts (OR 1.10, CI 1 to 1.22 and OR 1.21, CI 1.08 to 1.35) (table 
3).  
 
High levels of specialist nurse staffing were significantly associated with reports of better 
experience on some, but not all, items (table 3). In trusts with high levels of specialist 
nurse staffing patients were more likely to report that professionals worked well together 
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to provide best possible care  (OR 1.08, CI 1.01 to 1.15) and that they received enough 
emotional support (OR 1.15, CI 1.02 - 1.29, and OR 1.15 CI 1.01 - 1.32). However, high 
levels of nurse staffing were not significantly associated with patient reports of being 
treated as a set of cancer symptoms (OR 1.04 , CI  0.96 - 1.12 ) given the right amount of 
information (OR 0.96, 95% CI 0.88 - 1.05) support for symptom control for people 
undergoing chemotherapy (OR   1.13,CI  0.98 to 1.30  ) or radiotherapy (OR  1.04, CI  
0.88 to 1.22). (Table 3) 
 
As most specialist nurses focus on people with a particular cancer type we undertook a 
sub-group analyses exploring the association between experiences for women with breast 
cancer and the number of breast cancer specialist nurses. We restricted this analysis to 
breast because it was the most common type of cancer in our sample and because of the 
low number of patients and nurses for other tumours in most centres . Results were 
similar to those for the sample overall (Table 4) although associations were typically 
stronger and there was a significant association between high levels of breast specialist 
nurse staffing and perceptions of support for symptom control for those undergoing 
chemotherapy (OR 1.34, 95% CI  1.02 to1.75). 
 
We conducted several sensitivity checks. We repeated the analysis dropping seven trusts 
whose staffing levels were at the extremes of the distribution, which did not significantly 
change the models or conclusions. We repeated the analysis with staffing as a 
standardized continuous measure (mean=0, sd=1) without detecting any significant 
changes to the models. Because there appeared to be some association between trust sizes 
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and staffing levels, with larger trusts having fewer nurses per patient, we assessed models 
with the number of beds per trust as a proxy for trust size, however likelihood ratio tests 
showed that size did not contribute to the fit in any of the models tested.  
Discussion 
This is the first study to explore whether greater provision of specialist nurses in the 
workforce is associated with the intended goal – that is improved coordination, 
information and supportive care for patients.  Our results show that some, but not all 
aspects of patient experience in these areas were better where there were more specialist 
nurses. Patients in trusts with better specialist nurse staffing, that is those with fewer 
patients per specialist nurses, were more likely to be given the name of a specialist nurse 
and to find it easy to contact them. They were also more likely to feel that the clinical 
team worked well together.  They were more likely to feel that they were given enough 
emotional support while undergoing treatment and patients with breast cancer were more 
likely to feel that staff did everything possible to control side effects of chemotherapy. 
However, we did not find evidence that patients were more likely to feel they received 
the right amount of information and the absolute magnitudes of the differences we found 
are small. The largest (unadjusted) absolute difference was a 5.9% difference in the 
number of patients with breast cancer reporting they were given enough emotional 
support between high and low staffed trusts (73.9% vs 68%). 
 
This is a cross sectional study and so no causal inference can be made. Inevitably 
observational studies such as this suffer from large amounts of nuisance variation and a 
low “signal to noise” ratio for the relationships of interest. We used an existing survey 
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with items that were not designed to explicitly explore the hypothesised effects of 
specialist nurses. Nonetheless, we were able to select items from the survey which were 
relevant to the core functions outlined in policy documents and many of the relationships 
observed are plausibly associated with the work of specialist nurses even though the 
items may be insensitive measures of the relevant experiences.  
 
It is likely that there are other unmeasured factors in the organization and deployment of 
staff which are associated with both better specialist nurse staffing and better patient 
experience. One possibility is the so called ‘magnet effect’, where a number of 
organisational characteristics including leadership and management of the clinical 
(nursing) team, positive relationships between nurses and doctors and support for 
education and training of nursing staff are associated with both better staffing and better 
patient outcomes. (19)  However studies exploring these characteristics simultaneously in 
other clinical settings suggest that there is an independent effect for staffing, albeit one 
which interacts with other organizational factors. (20, 21)  
 
The expected impacts of increasing the specialist nurse workforce in cancer care are 
ambitious and important. This study demonstrates that such a strategy may be associated 
with benefits when routinely implemented. While the absolute magnitude of the 
associations we observed is small, the experiences measured are important and likely to 
reflect wider benefits for patients.  In addition to the intrinsic importance attached to a 
feeling of continuity, proper coordination of care has been linked to improved outcomes 
including quality of life(22) and failures of coordination and resulting discontinuities are 
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associated with adverse events. (23) Although the influence of psychosocial support on 
treatment outcomes for cancer care is unclear(24) emotional support is intrinsically 
important to patients and can reduce psychological morbidity. (25)  
 
Nonetheless the value of the small differences we observed is unclear. If the association 
was presumed to be causal and fully reflecting the benefit of higher specialist nurse 
staffing it seems unlikely that an economic case could be made for increasing staffing 
based on these findings alone. Previous research has shown benefits associated with 
therapeutic interventions delivered by specialist nurses(8, 9) but has not explored the 
global effects of introducing large numbers of specialist nurses into the workforce.  There 
is evidence of substantial variation in the roles of specialist nurses across trusts and 
between disease groups. (5, 6, 26) Many nurses in the census may be delivering little 
direct patient care. In the United States, clear distinctions are made between ‘clinical 
nurse specialists’, who coordinate care but generally do not deliver direct interventions, 
and other advanced practice nurses (for example nurse practitioners) who do. (27) There 
is no parallel system of registration and protection of these titles in England, which 
means that job title (recorded in the census) does not clearly indicate the actual role a 
nurse takes.   
 
The national survey showed that patients who said that they had been given the name of a 
clinical nurse specialist were far more likely to be given information on self-care support 
and treatment side effects for example, although we found no association between the 
size of the specialist nurse workforce and perceptions that patients had been given the 
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right amount of information. This may be because the global question we selected, about 
the quantity of information, does not directly assess the quality of communication and 
provision of understandable information. However, in the absence of a clear summative 
question on the successful transmission and comprehension of useful information, some 
uncertainty must remain which warrants further investigation. 
 
The findings of this study have their most direct relevance to policy in the United 
Kingdom where the goals of expanding the specialist cancer nursing workforce are 
clearly articulated and widely supported. However, the development of the multi-
disciplinary cancer workforce to improve outcomes is not unique to this setting. 
Specialist nursing roles are being adopted globally (28)  and cancer care is a frequent 
focus for the development. For example the Australian Government and Cancer Australia 
supported the National Cancer Nursing Education project which identified competencies 
for specialist cancer nurses which would match the goals intended for nurses in the UK. 
(29) Across Europe there is evidence of a growing role for cancer nurse specialists, but 
like the UK there is variation in the size and deployment of the workforce both between 
and with countries. (30)  
 
Conclusion 
These findings indicate that care coordination, supportive care and especially emotional 
support for patients with cancer, are better in trusts with more specialist nurses, although 
the relationship with information remains unproven. This study cannot be used to identify 
optimal staffing levels, but further investigation is warranted to explore service 
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configurations and nurse specialist roles that may be associated with improved 
experiences. There is a risk that reducing specialist nurse input, especially where it 
involves direct patient, care may lead to poorer patient experience.  
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